Holdings of ARK Genomic Revolution ETF
ARK ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 1.2B $ including 1.2B $ in equities, 99.6 %
- Positions
- 32 in 4 countries
- Top ten
- 58.8 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Tempus AI Inc | 2,098,455 | 116.4M $ | 9.42 % |
| 2 | Twist Bioscience Corp | 1,900,539 | 111.1M $ | 8.99 % |
| 3 | CRISPR Therapeutics AG | 2,103,707 | 110.1M $ | 8.91 % |
| 4 | 10X Genomics Inc | 3,232,541 | 71.3M $ | 5.77 % |
| 5 | Beam Therapeutics Inc | 2,212,153 | 67.1M $ | 5.43 % |
| 6 | Absci Corp | 11,876,202 | 59.1M $ | 4.78 % |
| 7 | Natera Inc | 243,718 | 50.2M $ | 4.07 % |
| 8 | Illumina Inc | 392,835 | 49.8M $ | 4.03 % |
| 9 | Intellia Therapeutics Inc | 3,498,399 | 47.2M $ | 3.82 % |
| 10 | Personalis Inc | 8,017,242 | 44.3M $ | 3.58 % |
| 11 | Recursion Pharmaceuticals Inc | 12,549,240 | 43.4M $ | 3.51 % |
| 12 | Guardant Health Inc | 496,000 | 43.2M $ | 3.49 % |
| 13 | CareDx Inc | 2,009,757 | 41.8M $ | 3.38 % |
| 14 | Veracyte Inc | 999,975 | 32.9M $ | 2.66 % |
| 15 | Compass Pathways plc | 3,316,076 | 30M $ | 2.43 % |
| 16 | Adaptive Biotechnologies Corp | 2,123,561 | 29.9M $ | 2.42 % |
| 17 | Nurix Therapeutics Inc | 1,723,734 | 28.8M $ | 2.33 % |
| 18 | GeneDx Holdings Corp | 401,292 | 25.2M $ | 2.04 % |
| 19 | Schrodinger Inc/United States | 2,093,199 | 25M $ | 2.03 % |
| 20 | Arcturus Therapeutics Holdings Inc | 2,809,043 | 24.2M $ | 1.96 % |
| 21 | Butterfly Network Inc | 4,889,029 | 23.4M $ | 1.89 % |
| 22 | Ionis Pharmaceuticals Inc | 288,230 | 21.5M $ | 1.74 % |
| 23 | AtaiBeckley Inc | 4,382,604 | 18.2M $ | 1.48 % |
| 24 | Prime Medicine Inc | 4,925,864 | 17.5M $ | 1.41 % |
| 25 | Pacific Biosciences of California Inc | 10,964,895 | 17.4M $ | 1.41 % |
| 26 | Cerus Corp | 7,450,534 | 15.1M $ | 1.22 % |
| 27 | Alamar Biosciences Inc | 596,585 | 14.9M $ | 1.21 % |
| 28 | 908 Devices Inc | 1,952,552 | 13.3M $ | 1.08 % |
| 29 | BioNTech SE | 126,929 | 13.1M $ | 1.06 % |
| 30 | Eli Lilly & Co | 12,571 | 11.7M $ | 0.95 % |
| 31 | Quantum-Si Inc | 6,928,343 | 6.8M $ | 0.55 % |
| 32 | Generate Biomedicines Inc | 503,531 | 6.4M $ | 0.51 % |
Sector breakdown
- Health care 10.8 %
- Unattributed 89.2 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 87.5 %
- Switzerland 8.9 %
- United Kingdom 2.4 %
- Germany 1.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 29 | 1.1B $ | 87.54 % |
| 2 | Switzerland | 1 | 110.1M $ | 8.95 % |
| 3 | United Kingdom | 1 | 30M $ | 2.44 % |
| 4 | Germany | 1 | 13.1M $ | 1.07 % |
Cite this page
Titelia. "Holdings of ARK Genomic Revolution ETF". https://titelia.com/en/funds/S000042975